Wordt geladen...
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
OBJECTIVE: Many patients receiving dual antiplatelet therapy still had recurrent strokes. We aimed to identify factors associated with recurrent stroke at 90 days in patients receiving dual antiplatelet therapy in Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events tria...
Bewaard in:
| Gepubliceerd in: | Stroke Vasc Neurol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5829906/ https://ncbi.nlm.nih.gov/pubmed/29507777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2017-000088 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|